Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Nov 23, 2015

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 27th Annual Piper Jaffray Healthcare Conference in New York on Wednesday, December 2 at noon Eastern Time. The...

Nov 16, 2015

Hologic, Inc. (Nasdaq: HOLX) announced today that the market research firm KLAS ranked Hologic products highest in the mammography category in its annual "Best in KLAS" awards. The ranking is...

Nov 12, 2015

Researchers presented a new clinical-economic modeling analysis this week showing that screening for cervical cancer with Pap+HPV Together™ (co-testing) using the Aptima® HPV assay (an...

Nov 4, 2015

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal fourth quarter ended September 26, 2015. The Company reported revenue of $702.8 million, GAAP diluted EPS of

More ›